Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor-Reference-Cited by-同舟云学术

Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor

Published:2018-10-30 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Patki Mugdha,McFall Thomas^ORCID,Rosati Rayna,Huang Yanfang,Malysa Agnes,Polin Lisa,Fielder Abigail,Wilson Mike R.,Lonardo Fulvio,Back Jessica,Li Jing,Matherly Larry H.,Bepler Gerold,Ratnam Manohar

Funder

Division of Cancer Prevention, National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-34475-8.pdf

Reference30 articles.

1. Scagliotti, G. V. et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 26, 3543–3551, https://doi.org/10.1200/jco.2007.15.0375 (2008).

2. Ciuleanu, T. et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study. Lancet 374, 1432–1440, https://doi.org/10.1016/s0140-6736(09)61497-5 (2009).

3. Reck, M. et al. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med 375, 1823–1833, https://doi.org/10.1056/NEJMoa1606774 (2016).